Next-Generation GLP-1 Agonists (2010s): Liraglutide, Pramlintide, Dulaglutide, and More With the success of exenatide, other GLP-1 analogues rapidly advanced through development
For weight management , certain GLP-1 formulations (liraglutide 3.0mg [Saxenda] and semaglutide 2.4mg [Wegovy]) are licensed for chronic weight management in adults with: BMI 30 kg/m , or BMI 27 kg/m with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, or dyslipidaemia) However, NHS access to these medications for weight management is typically restricted to specialist tier 3 or tier 4 weight management services, with specific eligibility criteria defined by NICE technology appraisals (TA494 for liraglutide, TA664 for semaglutide) and local commissioning arrangements
Take Davidson, the bodybuilder, who is gearing up for a couple of Mr
Finally, there are potential mental health issues that a young athlete may contend with if theyre using or considering a GLP-1 drug
